Redhill Biopharma Stock Price History

RDHL Stock  USD 1.86  0.56  23.14%   
Below is the normalized historical share price chart for Redhill Biopharma extending back to January 07, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Redhill Biopharma stands at 1.86, as last reported on the 20th of July, with the highest price reaching 2.12 and the lowest price hitting 1.86 during the day.
IPO Date
7th of January 2013
200 Day MA
4.6539
50 Day MA
1.9345
Beta
4.222
 
Yuan Drop
 
Covid
If you're considering investing in Redhill Stock, it is important to understand the factors that can impact its price. Redhill Biopharma maintains Sharpe Ratio (i.e., Efficiency) of -0.0165, which implies the firm had a -0.0165 % return per unit of risk over the last 3 months. Redhill Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Redhill Biopharma's Risk Adjusted Performance of (0.02), variance of 31.16, and Coefficient Of Variation of (3,870) to confirm the risk estimate we provide.
At this time, Redhill Biopharma's Common Stock Shares Outstanding is quite stable compared to the past year. Common Stock is expected to rise to about 36.8 M this year, although the value of Total Stockholder Equity is projected to rise to (4.4 M). . The value of Price To Sales Ratio is estimated to slide to 1.81. The value of Price Earnings Ratio is estimated to slide to -1.94. Redhill Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0165

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRDHL

Estimated Market Risk

 5.51
  actual daily
49
51% of assets are more volatile

Expected Return

 -0.09
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Redhill Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Redhill Biopharma by adding Redhill Biopharma to a well-diversified portfolio.
Price Book
203.2068
Enterprise Value Ebitda
0.3005
Price Sales
0.5308
Shares Float
11.5 B
Wall Street Target Price
19 K

Redhill Biopharma Stock Price History Chart

There are several ways to analyze Redhill Stock price data. The simplest method is using a basic Redhill candlestick price chart, which shows Redhill Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJuly 17, 20252.42
Lowest PriceJune 13, 20251.75

Redhill Biopharma July 20, 2025 Stock Price Synopsis

Various analyses of Redhill Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Redhill Stock. It can be used to describe the percentage change in the price of Redhill Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Redhill Stock.
Redhill Biopharma Price Daily Balance Of Power(2.15)
Redhill Biopharma Price Action Indicator(0.41)
Redhill Biopharma Price Rate Of Daily Change 0.77 

Redhill Biopharma July 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Redhill Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Redhill Biopharma intraday prices and daily technical indicators to check the level of noise trading in Redhill Stock and then apply it to test your longer-term investment strategies against Redhill.

Redhill Stock Price History Data

The price series of Redhill Biopharma for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 0.67 with a coefficient of variation of 8.34. The price distribution for the period has arithmetic mean of 2.0. The median price for the last 90 days is 1.96. The company completed stock split (1:25) on 20th of August 2024.
OpenHighLowCloseVolume
07/20/2025
 2.10  2.12  1.86  1.86 
07/18/2025 2.10  2.12  1.86  1.86  174,421 
07/17/2025 1.95  2.62  1.90  2.42  443,400 
07/16/2025 1.91  1.98  1.88  1.96  32,813 
07/15/2025 2.17  2.17  1.90  1.91  27,115 
07/14/2025 2.19  2.19  2.14  2.18  6,403 
07/11/2025 2.14  2.19  2.11  2.19  11,495 
07/10/2025 2.09  2.15  2.07  2.13  12,018 
07/09/2025 2.10  2.13  2.05  2.09  11,526 
07/08/2025 2.00  2.10  2.00  2.10  16,476 
07/07/2025
 2.02  2.06  2.01  2.06  11,476 
07/03/2025
 2.01  2.03  1.97  2.03  11,508 
07/02/2025 1.98  2.03  1.95  2.00  10,451 
07/01/2025
 1.94  2.08  1.90  2.02  43,264 
06/30/2025
 1.88  1.94  1.86  1.94  14,294 
06/27/2025
 1.78  1.89  1.75  1.86  9,861 
06/26/2025 1.77  1.85  1.76  1.82  21,160 
06/25/2025
 1.94  1.94  1.84  1.87  13,564 
06/24/2025
 1.89  1.94  1.84  1.94  10,112 
06/23/2025 1.90  1.90  1.82  1.89  12,545 
06/20/2025
 1.85  1.90  1.82  1.90  22,426 
06/18/2025
 1.78  1.84  1.78  1.84  10,895 
06/17/2025
 1.78  1.79  1.75  1.77  34,200 
06/16/2025
 1.75  1.79  1.73  1.78  25,982 
06/13/2025
 1.91  1.91  1.72  1.75  45,800 
06/12/2025
 2.00  2.00  1.92  1.94  12,698 
06/11/2025
 2.05  2.05  1.97  2.00  16,654 
06/10/2025
 2.05  2.05  1.99  2.03  16,627 
06/09/2025
 1.99  2.08  1.98  2.05  26,841 
06/06/2025
 1.96  1.99  1.86  1.99  11,572 
06/05/2025
 1.92  1.94  1.85  1.93  15,926 
06/04/2025
 1.86  1.92  1.82  1.92  26,940 
06/03/2025
 1.83  1.91  1.83  1.86  13,917 
06/02/2025
 1.81  1.81  1.74  1.80  7,038 
05/30/2025
 1.75  1.80  1.73  1.79  14,796 
05/29/2025
 1.78  1.81  1.75  1.76  12,930 
05/28/2025
 1.83  1.83  1.77  1.80  13,289 
05/27/2025
 1.84  1.85  1.77  1.84  25,260 
05/23/2025
 1.77  1.85  1.77  1.84  5,532 
05/22/2025
 1.80  1.85  1.76  1.85  16,841 
05/21/2025
 1.87  1.93  1.82  1.90  18,137 
05/20/2025
 1.82  1.90  1.81  1.90  7,467 
05/19/2025
 1.90  1.92  1.85  1.90  26,967 
05/16/2025
 1.79  1.85  1.77  1.85  23,288 
05/15/2025
 1.80  1.89  1.76  1.81  44,843 
05/14/2025
 1.88  1.91  1.81  1.88  86,331 
05/13/2025
 1.97  2.03  1.71  1.89  3,878,231 
05/12/2025
 2.02  2.05  1.93  2.00  23,798 
05/09/2025
 1.99  2.03  1.94  2.00  8,060 
05/08/2025
 1.89  2.03  1.85  1.98  40,206 
05/07/2025
 1.93  1.94  1.91  1.91  13,279 
05/06/2025
 2.18  2.18  1.76  1.93  73,718 
05/05/2025
 2.14  2.15  2.06  2.10  23,738 
05/02/2025
 2.15  2.17  2.05  2.07  21,689 
05/01/2025
 2.15  2.21  2.10  2.15  17,739 
04/30/2025
 2.18  2.21  2.08  2.21  20,085 
04/29/2025
 2.17  2.30  2.16  2.23  40,932 
04/28/2025
 2.36  2.40  2.10  2.17  105,883 
04/25/2025
 2.32  2.42  2.29  2.41  35,269 
04/24/2025
 2.27  2.37  2.23  2.32  59,697 
04/23/2025
 2.48  2.48  2.22  2.24  84,967 

About Redhill Biopharma Stock history

Redhill Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Redhill is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Redhill Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Redhill Biopharma stock prices may prove useful in developing a viable investing in Redhill Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding2.5 M2.6 M
Net Loss-88 M-83.6 M

Redhill Biopharma Stock Technical Analysis

Redhill Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Redhill Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Redhill Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Global Correlations Now

   

Global Correlations

Find global opportunities by holding instruments from different markets
All  Next Launch Module

Redhill Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Redhill Biopharma's price direction in advance. Along with the technical and fundamental analysis of Redhill Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Redhill to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Redhill Biopharma is a strong investment it is important to analyze Redhill Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Redhill Biopharma's future performance. For an informed investment choice regarding Redhill Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Redhill Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
6.527
Quarterly Revenue Growth
3.82
Return On Assets
(0.37)
Return On Equity
(17.09)
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.